Faiyaz Ahmed Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Faiyaz Ahmed Khan has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Gazi Md. Salahuddin Mamun
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B)
2 shared publications - Mohammad Abdul Aleem
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka 1212, Bangladesh
2 shared publications - Nusrat Jahan Shaly
Infectious Diseases Division (IDD), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68, Sheheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh
2 shared publications - Sayeeda Huq
Office of Executive Director (OED), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68, Sheheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh
2 shared publications - Tanzir Ahmed Shuvo
Infectious Diseases Division (IDD), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68, Sheheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh
2 shared publications - Zakir Hossain Habib
Institute of Epidemiology, Disease Control and Research, 44 Mohakhali, Dhaka 1212, Bangladesh
2 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2624
High Burden and Persistent Detection of Kodamaea ohmeri Bloodstream Infection Among Neonates in Bangladesh: A Prospective Hospital-Based Surveillance
Kodamaea ohmeri is an emerging invasive fungal pathogen, with limited data from low- and middle-income countries. We describe the epidemiology, clinical characteristics, and outcomes of neonatal K. ohmeri bloodstream infection in two tertiary care hospitals in Bangladesh. We conducted prospective surveillance among neonates admitted to neonatal intensive care units of two tertiary care hospitals between August 2022 and June 2026. Fungal isolates were identified using VITEK 2 and confirmed using VITEK MS. Antifungal susceptibility testing (AFST) was performed on a subset of isolates using two gradient diffusion strip tests. Among 770 enrolled neonates, 12.3% (n = 95) had bloodstream infection caused by K. ohmeri, accounting for 27.1% of all positive fungal isolates. Clinical characteristics were comparable between K. ohmeri and other fungal infections. Among the positive K. ohmeri cases, 57.9% (n = 55) received antifungal therapy. AFST showed relatively higher fluconazole MICs than voriconazole, amphotericin B, and echinocandins. However, mortality was numerically lower among patients who received antifungal therapy than among those who did not, although the association was not statistically significant in either unadjusted (p = 0.09) or adjusted (p = 0.065) analyses. The high burden and associated mortality of K. ohmeri bloodstream infections highlight the importance of strengthening species-level fungal identification and antifungal stewardship in resource-limited NICUs. Continued surveillance and further investigations linking antifungal susceptibility with clinical outcomes are warranted to inform evidence-based management.
- 12 November 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2624
Open AccessHigh Burden and Persistent Detection of Kodamaea ohmeri Bloodstream Infection Among Neonates in Bangladesh: A Prospective Hospital-Based Surveillance
Kodamaea ohmeri is an emerging invasive fungal pathogen, with limited data from low- and middle-income countries. We describe the epidemiology, clinical characteristics, and outcomes of neonatal K. ohmeri bloodstream infection in two tertiary care hospitals in Bangladesh. We conducted prospective surveillance among neonates admitted to neonatal intensive care units of two tertiary care hospitals between August 2022 and June 2026. Fungal isolates were identified using VITEK 2 and confirmed using VITEK MS. Antifungal susceptibility testing (AFST) was performed on a subset of isolates using two gradient diffusion strip tests. Among 770 enrolled neonates, 12.3% (n = 95) had bloodstream infection caused by K. ohmeri, accounting for 27.1% of all positive fungal isolates. Clinical characteristics were comparable between K. ohmeri and other fungal infections. Among the positive K. ohmeri cases, 57.9% (n = 55) received antifungal therapy. AFST showed relatively higher fluconazole MICs than voriconazole, amphotericin B, and echinocandins. However, mortality was numerically lower among patients who received antifungal therapy than among those who did not, although the association was not statistically significant in either unadjusted (p = 0.09) or adjusted (p = 0.065) analyses. The high burden and associated mortality of K. ohmeri bloodstream infections highlight the importance of strengthening species-level fungal identification and antifungal stewardship in resource-limited NICUs. Continued surveillance and further investigations linking antifungal susceptibility with clinical outcomes are warranted to inform evidence-based management.
- Open Access
- 25 March 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
High burden of Candida blankii (syn.Tardiomyces blankii) bloodstream infections among neonates in an intensive care unit in Bangladesh
Invasive fungal infections (IFIs) remain underrecognized in low- and middle-income countries due to limited surveillance. This study aims to report the bur
- 25 March 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessHigh burden of Candida blankii (syn.Tardiomyces blankii) bloodstream infections among neonates in an intensive care unit in Bangladesh
Invasive fungal infections (IFIs) remain underrecognized in low- and middle-income countries due to limited surveillance. This study aims to report the bur